The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation

Anesthesia and Analgesia

Volumn 95, Issue 4, 2002, Pages 858-865

  Innerhofer, Petra ^a   Fries, Dietmar ^a   Margreiter, Josef ^a   Klingler, Anton ^a   Kühbacher, Gabriele ^a   Wachter, Bernhard ^a   Oswald, Elgar ^a   Salner, Erwin ^a   Frischhut, Bernhard ^a   Schobersberger, Wolfgang ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANESTHETIC AGENT; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8; BUPIVACAINE; CEPHALOSPORIN DERIVATIVE; ENOXAPARIN; FIBRINOGEN; GELATIN; HEMOGLOBIN; HETASTARCH; LOW MOLECULAR WEIGHT HEPARIN; RINGER LACTATE SOLUTION; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANESTHETIC EQUIPMENT; ARTICLE; BLOOD CLOTTING; COLLOID; CRYSTALLOID; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REGIONAL ANESTHESIA; THROMBOCYTE FUNCTION; THROMBOEMBOLISM;

EID: 0036785686     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200210000-00012     Document Type: Article

References (24)

1. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-9.
2. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998;316:961-4.
3. Roberts J, Evans P, Bunn F, et al. Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet 2001;357: 385-7.
4. Egli GA, Zollinger A, Seifert B, et al. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997;78:684-9.
5. Petroianu GA, Liu J, Maleck WH, et al. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastography®. Anesth Analg 2000; 90:795-800.
6. Mardel SN, Saunders F, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998;80:204-7.
7. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996;76:412-4.
8. Karoutsos S, Nathan N, Lahrimi A, et al. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999;82:175-7.
9. Stögermüller B, Stark J, Willschke H, et al. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000;91: 823-7.
10. de Jonge E, Levi M, Berends F, et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998;79:286-90.
11. Hüttner I, Boldt J, Haisch G, et al. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth 2000;85:417-23.
12. Ruttmann TG, James MF, Aroson I. In vivo investigation into the effects of hemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998;80:612-6.
13. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998;91:1325-31.
14. Mammen EF, Rasheed S, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100™ system. Semin Thromb Hemost 1995;21:113-21.
15. Miller BE, Guzzetta NA, Tonsone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000;90: 1324-30.
16. Gottumukkala VNR, Shrama SK, Philip J. Assessing platelet and fibrinogen contributing to clot strength using modified thrombo-elastography in pregnant women. Anesth Analg 1999;89: 1453-5.
17. Calatzis A, Haas S, Gödje O, et al. Thrombelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer. In: Piffaré R, ed. Management of bleeding in cardiovascular surgery. Philadelphia: Hanley & Belfus, 2000:215-26.
18. Kövesi T, Royston D. Is there a bleeding problem with platelet-active drugs? Br J Anaesth 2002;88:159-63.
19. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002;94: 1280-7.
20. Beumer S, Heijnen HF, Ijsseldijk MJ, et al. Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib. Blood 1995;86:3452-60.
21. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995;81:360-5.
22. Haisch G, Boldt J, Krebs C, et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-71.
23. Fries D, Innerhofer P, Schobersberger W. Coagulation management in trauma patients. Curr Opin Anaesthesiol 2002;5:217-33.
24. McLaughlin TM, Fontana JF, Alving B, et al. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 1996;83:459-65.